Enterocolonic Mycobacterium avium-intracellulare.
Wu
Mark Li-cheng
ML
Department of Pathology and Laboratory Medicine, University of California Los Angeles School of Medicine, USA. mark.wu@ucdmc.ucdavis.edu
Poles
Michael A
MA
Thompson
Andrew D
AD
Dry
Sarah M
SM
D000163:Acquired Immunodeficiency Syndrome / Q000382:microbiology / Q000473:pathology; D000328:Adult; D017963:Azithromycin / Q000627:therapeutic use; D003108:Colonic Diseases / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D017809:Fatal Outcome; D016586:Granular Cell Tumor / Q000473:pathology; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D009164:Mycobacterium Infections / Q000473:pathology; D015269:Mycobacterium avium Complex / Q000235:genetics / Q000302:isolation & purification*; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology*; D021141:Nucleic Acid Amplification Techniques; D012329:RNA, Bacterial / Q000032:analysis; D017828:Rifabutin / Q000627:therapeutic use; D008061:Whipple Disease / Q000473:pathology
D012329:RNA, Bacterial; D017828:Rifabutin; D017963:Azithromycin; D004977:Ethambutol